Skip to main navigation Skip to search Skip to main content

Mortality reduction with administration of abciximab during primary PCI is confined to STEMI patients with complex lesions

Allan Zeeberg Iversen, Søren Galatius, Ulrik Abildgaard, Jan Skov Jensen

    57 Downloads (Pure)

    Cite this